Logo image of ACAX

ALSET CAPITAL ACQUISITI-CL A (ACAX) Stock Fundamental Analysis

NASDAQ:ACAX - Nasdaq - US02115M1099 - Common Stock - Currency: USD

3.82  -6.48 (-62.91%)

After market: 4.1 +0.28 (+7.33%)

Fundamental Rating

1

Overall ACAX gets a fundamental rating of 1 out of 10. We evaluated ACAX against 0 industry peers in the Unkown industry. ACAX has a bad profitability rating. Also its financial health evaluation is rather negative. ACAX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACAX was profitable.
In the past year ACAX has reported a negative cash flow from operations.
ACAX Yearly Net Income VS EBIT VS OCF VS FCFACAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 -200K -400K -600K

1.2 Ratios

Industry RankSector Rank
ROA 3.99%
ROE 4.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACAX Yearly ROA, ROE, ROICACAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 0 -10 -20 -30 -40

1.3 Margins

ACAX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACAX Yearly Profit, Operating, Gross MarginsACAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ACAX has more shares outstanding
There is no outstanding debt for ACAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACAX Yearly Shares OutstandingACAX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2M 4M 6M 8M 10M
ACAX Yearly Total Debt VS Total AssetsACAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.54 indicates that ACAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACAX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACCN/A
WACCN/A
ACAX Yearly LT Debt VS Equity VS FCFACAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M 60M 80M

2.3 Liquidity

ACAX has a Current Ratio of 1.51. This is a normal value and indicates that ACAX is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.51 indicates that ACAX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
ACAX Yearly Current Assets VS Current LiabilitesACAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAX Yearly Revenue VS EstimatesACAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022
ACAX Yearly EPS VS EstimatesACAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACAX is valuated quite expensively with a Price/Earnings ratio of 63.67.
Compared to an average S&P500 Price/Earnings ratio of 29.63, ACAX is valued quite expensively.
Industry RankSector Rank
PE 63.67
Fwd PE N/A
ACAX Price Earnings VS Forward Price EarningsACAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACAX Per share dataACAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALSET CAPITAL ACQUISITI-CL A

NASDAQ:ACAX (1/8/2024, 8:00:00 PM)

After market: 4.1 +0.28 (+7.33%)

3.82

-6.48 (-62.91%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners26.65%
Inst Owner Change-4.68%
Ins Owners10.56%
Ins Owner Change0%
Market Cap17.61M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 63.67
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)0.06
EY1.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0
BVpS3.98
TBVpS3.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 4.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 2.54
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6800%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A